Chapter title |
Venous Thromboembolism in Brain Tumor Patients
|
---|---|
Chapter number | 117 |
Book title |
Thrombosis and Embolism: from Research to Clinical Practice
|
Published in |
Advances in experimental medicine and biology, September 2016
|
DOI | 10.1007/5584_2016_117 |
Pubmed ID | |
Book ISBNs |
978-3-31-922107-6, 978-3-31-922108-3
|
Authors |
Mohammed Jeraq M.D., David J. Cote, Timothy R. Smith M.D., Ph.D., M.P.H., Mohammed Jeraq, Timothy R. Smith |
Editors |
Md. Shahidul Islam |
Abstract |
Venous thromboembolism (VTE) is a common medical condition, particularly after surgical interventions. Many studies have shown that development of VTE, including both deep vein thrombosis (DVT) and pulmonary embolism (PE), is more common in surgical patients with cancer than in patients without cancer. This chapter focuses on VTE in brain tumor patients, including their pathogenesis, presentation, diagnosis, and treatment. Topics discussed included a brief overview of VTE followed by an in-depth discussion of the VTE risks brain tumor patients face in the post-operative period. We conclude with a summary of various recommendations on VTE prophylaxis and a discussion of the controversial nature of VTE chemoprophylaxis for patients undergoing transcranial operations for brain tumors. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 29 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 5 | 17% |
Researcher | 4 | 14% |
Student > Doctoral Student | 2 | 7% |
Student > Bachelor | 2 | 7% |
Student > Ph. D. Student | 2 | 7% |
Other | 4 | 14% |
Unknown | 10 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 31% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Engineering | 1 | 3% |
Unknown | 16 | 55% |